Urination disorder-improving agent
AssigneeAska Pharmaceutical Co., Ltd.
InventorsHideo Kobayashi, Atsushi Shinbo, Youichi Nakano, Yuta Ito, Junichi Watanabe
Life of this patent
Estimating the term…
Abstract
Provided is a urination disorder-improving agent useful for treating or improving (or alleviating) a urination disorder regardless of the degree or presence of prostatomegaly. The urination disorder-improving agent contains a 2-oxapregnane compound represented by the following formula (1) as an active ingredient. (In the formula, R1 to R3 represent an alkyl group such as methyl group, R4 represents an alkylcarbonyl group such as acetyl group, X represents a halogen atom such as a chlorine atom, Y represents a hydroxyl group or oxo group bonded to the 11-position, 15-position, or 16-position of the steroid skeleton.)
Claims7
A method of improving a urination disorder, the method comprising administering a therapeutically effective amount of a urination disorder-improving agent comprising 17α-acetoxy-6-chloro-15ß-hydroxy-2-oxa-4,6-pregnadiene-3,20-dione as an active ingredient to a subject.
Dependencies are inferred from the claim text.